tiprankstipranks
Trending News
More News >
Cell Impact AB (SE:CI)
:CI
Sweden Market

Cell Impact AB (CI) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Cell Impact AB’s (CI) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Cell Impact AB is a Sell.
Cell Impact AB’s (CI) 20-Day exponential moving average is 0.08, while Cell Impact AB’s (CI) share price is <kr0.1, making it a Sell.
Cell Impact AB’s (CI) 50-Day exponential moving average is 0.09, while Cell Impact AB’s (CI) share price is <kr0.1, making it a Sell.

Cell Impact AB (CI) Pivot Points

May 13, 2025, 05:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.08
0.08
0.08
0.09
0.09
Fibonacci
0.07
0.08
0.08
0.08
0.08
0.08
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cell Impact AB (CI) Moving Averages

May 13, 2025, 05:51 PM
Period
Simple
Exponential
MA5
0.08Buy
0.08Sell
MA10
0.08Sell
0.08Sell
MA20
0.08Buy
0.08Sell
MA50
0.09Sell
0.09Sell
MA100
0.11Sell
0.11Sell
MA200
0.17Sell
0.16Sell
Cell Impact AB’s (CI) 10-Day exponential moving average is 0.08, while Cell Impact AB’s (CI) share price is <kr0.1, making it a Sell.
Cell Impact AB’s (CI) 100-Day exponential moving average is 0.11, while Cell Impact AB’s (CI) share price is <kr0.1, making it a Sell.
Cell Impact AB’s (CI) stock price is <kr0.1 and Cell Impact AB’s (CI) 50-day simple moving average is 0.09, creating a Sell signal.
Cell Impact AB’s (CI) stock price is <kr0.1 and Cell Impact AB’s (CI) 100-day simple moving average is 0.11, creating a Sell signal.
Cell Impact AB’s (CI) stock price is <kr0.1 and Cell Impact AB’s (CI) 200-day simple moving average is 0.17, creating a Sell signal.

Cell Impact AB (CI) Technical Indicators

May 13, 2025, 05:51 PM
Name
Value
Implied Action
RSI (14)
43.02
Neutral
STOCH (9,6)
41.67
Neutral
STOCHRSI (14)
41.67
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
7.28
Buy
Williams %R
-58.33
Buy
CCI (14)
-58.58
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
54.98
Neutral
ROC
0.00
Sell
Cell Impact AB’s (CI) Relative Strength Index (RSI) is 43.02, creating a Neutral signal.
Cell Impact AB’s (CI) Trend Strength Indicator (ADX) is 7.28, creating a Buy signal.
Cell Impact AB’s (CI) Commodity Channel Index (CCI) is -58.58, creating a Neutral signal.

FAQ

Is CI a Buy, Hold, or Sell?
Based on CI’s technical indicators, CI is a Sell.
    What is CI’s RSI (14)?
    CI’s RSI (14) is 43.02, which suggests CI is a Neutral.
      What is CI’s MACD?
      CI’s MACD is >-0.01, which suggests CI is a Sell.
        What is CI’s 5-day moving average?
        CI’s 5-day moving average is 0.08, which suggests CI is a Buy.
          What is CI’s 20-day moving average?
          CI 20-day moving average is 0.08, which suggests CI is a Buy.
            What is CI’s 50-day moving average?
            CI’s 50-day moving average is 0.09, which suggests CI is a Sell.
              What is CI’s 200-day moving average?
              CI’s 200-day moving average is 0.17, which suggests CI is a Sell.
                What is CI’s Williams % R (14)?
                CI’s Williams % R (14) is -58.33, which suggests CI is a Buy.
                  What is CI’s CCI (14)?
                  CI’s CCI (14) is -58.58, which suggests CI is a Neutral.
                    What is the share price of Cell Impact AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis